Personalized immunoglobulin aptamers for detection of multiple myeloma minimal residual disease in serum

Multiple myeloma (MM) is a neoplasm of plasma cells that secrete patient specific monoclonal immunoglobulins. A recognized problem in MM treatment is the early recognition of minimal residual disease (MRD), the major cause of relapse. Current MRD detection methods (multiparameter flow cytometry and...

Descripción completa

Detalles Bibliográficos
Autores principales: Tapia-Alveal, Claudia, Olsen, Timothy R., Worgall, Tilla S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747622/
https://www.ncbi.nlm.nih.gov/pubmed/33335255
http://dx.doi.org/10.1038/s42003-020-01515-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747622/
https://www.ncbi.nlm.nih.gov/pubmed/33335255
http://dx.doi.org/10.1038/s42003-020-01515-x

Ejemplares similares